sk&f 81297 has been researched along with Idiopathic Parkinson Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dupre, KB | 1 |
| Eskow, KL | 1 |
| Barnum, CJ | 1 |
| Bishop, C | 1 |
| Vermeulen, RJ | 1 |
| Drukarch, B | 1 |
| Sahadat, MC | 1 |
| Goosen, C | 1 |
| Wolters, EC | 1 |
| Stoof, JC | 1 |
| Ekesbo, A | 1 |
| Andrén, PE | 1 |
| Gunne, LM | 1 |
| Sonesson, C | 1 |
| Tedroff, J | 1 |
3 other studies available for sk&f 81297 and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic Agents; Animals; Benzazepines; Biogenic Monoamine | 2008 |
The selective dopamine D1 receptor agonist, SKF 81297, stimulates motor behaviour of MPTP-lesioned monkeys.
Topics: Analysis of Variance; Animals; Benzazepines; Disease Models, Animal; Dopamine Agents; Ergolines; Mac | 1993 |
Motor effects of (-)-OSU6162 in primates with unilateral 6-hydroxydopamine lesions.
Topics: Adamantane; Animals; Apomorphine; Benzazepines; Benzopyrans; Callithrix; Dopamine Antagonists; Dose- | 2000 |